BRAFV600E mutation results in constitutive activation of the mitogen-activated protein kinase (MAPK) pathway; it has been observed that the MAPK pathway is also activated in cases of LCH without mutations of BRAF [37]. This evidence concerns the gene BRAF and Langerhans cell histiocytosis.